About
BioXcellerator is a global leader in advanced stem cell therapy and regenerative medicine, headquartered in Phoenix, Arizona, with a primary treatment clinic in Medellín, Colombia. Since 2018, the company has focused on alleviating pain and improving quality of life through evidence-based cell therapies. With a team of over 50 scientists, physicians, and researchers, BioXcellerator operates in the biotech sector and has shown significant growth potential. The company offers customized treatments for a variety of conditions, including autoimmune disorders, spine and disc issues, sports injuries, chronic pain, and more. BioXcellerator utilizes donor-derived mesenchymal stem cells sourced from Wharton's Jelly, ensuring high potency and purity. Their innovative approach includes a patent-pending protocol that combines these stem cells with exosomes to enhance regenerative effects. The company also operates a fully integrated regenerative medicine platform, ensuring complete oversight of the treatment process.